Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

Sector: Medicinal Chemicals And Botanical Products Region: India

: | Bombay Stock Exchange: 524715

Similar to: Cyanotech Corp.

× We're Sorry! We do not have an investor kit available for this company. Tell us you want one!

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

August 2013 Investor Presentation

Sun Pharmaceutical Industries Ltd. video

August 2013 Investor Presentation


Israel Makov, Chairman
Mr. Israel Makov is the former President and CEO of Teva Pharmaceutical Industries Ltd. He joined Teva in 1995 and led the company's global expansion, managing over 12 acquisitions, two of which were the largest M&A deals in Israeli history at the time. Prior to joining Teva, Mr. Makov led a number of companies in various industries, and founded Israel's first biotech company, Interpharm, which was the first Israeli company at the R&D stage to go public in the United States.

Currently, Mr. Israel Makov is Chairman of Given Imaging, a pioneer developer and the world's leading provider of capsule endoscopy; Chairman of Biolight, a life sciences investment company; Chairman of Micromedic Technologies Ltd., a cluster of companies engaged in cancer diagnostics, and Chairman of Eltav, a pioneer of wireless monitoring of industrial valves. Mr Makov is also the former Chairman of Netafim, the global leader in smart irrigation solutions. His other notable engagements include member of the Board of Directors of the Israel National Nanotechnology Initiative, a member of the Executive Board and Management Committee of the Weizmann Institute of Science, a member of the Board of Governors of the Technion Israel Institute of Technology, Chairman of the Board of the Institute for Policy and Strategy at the Interdisciplinary Center of Herzliya, Director at Artist Pension Trust and President of the Friends of Schneider Children’s Medical Center of Israel.

Mr. Israel Makov holds a B.Sc. in Agriculture and M.Sc. in Economics from the Hebrew University, Jerusalem.
Dilip S. Shanghvi , Managing Director

Mr. Dilip S. Shanghvi is the founder of Sun Pharmaceutical Industries Ltd. and has extensive industrial experience in the pharmaceutical industry. A first generation entrepreneur, Mr. Shanghvi has won numerous awards and recognitions, including CNN IBN’s Indian of the Year (Business) (2012), Business India's Businessman of the Year (2012) and Ernst and Young's World Entrepreneur of the Year (2011). He has also been awarded the Economic Times' Entrepreneur of the Year (2008), Business Standard’s CEO of the Year (2008) and CNBC TV 18's First Generation Entrepreneur of the Year (2007).

Mr. Shanghvi is also Chairman and Managing Director of Sun Pharma Advanced Research Company Ltd., and Chairman of the Shantilal Shanghvi Foundation. He holds a B.Com. from Kolkata University.
Sudhir V. Valia , Executive Director

Mr. Sudhir V. Valia is a Member of the Institute of Chartered Accountants of India and carries more than three decades of taxation and finance experience. He has been a director of Sun Pharma since the inception of the company and is also on the board of Taro Pharmaceuticals Ltd..
Mr. Valia has won CNBC TV18's CFO of the Year in the Pharmaceutical and Healthcare Sectors for two consecutive years (2011 and 2012). He has also been awarded the Adivasi Sevak Puraskar (2008-09) by the Government of Maharashtra for his contribution towards the welfare of tribals, particularly in the field of education in his capacity as director of the Shantilal Shanghvi Foundation.
Sailesh T. Desai, Executive Director
Mr. Sailesh T. Desai has more than 28 years of industrial experience, 18 of which have been in the pharmaceutical industry. Mr. Desai has had comprehensive corporate affairs experience, being involved in the turnaround at Milmet prior to Sun’s acquisition as well as in the early stages of the company's growth. He holds a B.Sc. from Kolkata University.

News & Analysis

You may also be interested in: